share_log

ADC Therapeutics Price Target Cut to $55.00/Share From $56.00 by Morgan Stanley

Dow Jones Newswires ·  Mar 23, 2021 19:57

DJ ADC Therapeutics Is Maintained at Overweight by Morgan Stanley

Ratings actions from Benzinga: https://www.benzinga.com/stock/ADCT/ratings

(END) Dow Jones Newswires

March 23, 2021 07:57 ET (11:57 GMT)

DJ ADC Therapeutics Price Target Cut to $55.00/Share From $56.00 by Morgan Stanley

Ratings actions from Benzinga: https://www.benzinga.com/stock/ADCT/ratings

(END) Dow Jones Newswires

March 23, 2021 07:57 ET (11:57 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment